Acadian Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $4.4M | Buy |
|
|||||
|
2022
Q3 | $4.21M | Sell |
|
|||||
|
2022
Q2 | $3.55M | Buy |
|
|||||
|
2022
Q1 | $2.67M | Buy |
|
|||||
|
2021
Q4 | $2.46M | Buy |
|
|||||
|
2021
Q3 | $2.29M | Buy |
|
|||||
|
2021
Q2 | $2.59M | Buy |
|
|||||
|
2021
Q1 | $2.66M | Buy |
|
|||||
|
2020
Q4 | $1.3M | Sell |
|
|||||
|
2020
Q3 | $1.1M | Sell |
|
|||||
|
2020
Q2 | $1.58M | Sell |
|
|||||
|
2020
Q1 | $1.64M | Sell |
|
|||||
|
2019
Q4 | $2.13M | Sell |
|
|||||
|
2019
Q3 | $1.56M | Sell |
|
|||||
|
2019
Q2 | $4.09M | Sell |
|
|||||
|
2019
Q1 | $6.46M | Sell |
|
|||||
|
2018
Q4 | $8.24M | Sell |
|
|||||
|
2018
Q3 | $13.8M | Sell |
|
|||||
|
2018
Q2 | $15.8M | Buy |
|
|||||
|
2018
Q1 | $19.4M | Buy |
|
|||||
|
2017
Q4 | $7.71M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $661K | Sell |
|
|||||
|
2016
Q2 | $3.09M | Buy |
|
|||||
|
2016
Q1 | $1.4M | Buy |
|
|||||
|
2015
Q4 | $818K | Buy |
|
|||||
|
2015
Q3 | $279K | Buy |
|